Can-Fite BioPharma Ltd. (CANF) stock
CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.49−0.06 (-3.87%)
Close on Nov 12, 2026Market cap $1.95MP/E –Yield –
Can-Fite BioPharma ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was -$9.93M. The highest annual figure on record is -$5.40M in fiscal 2018.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.93M | – |
| FY2024 | Dec 31, 2024 | -$8.12M | – |
| FY2023 | Dec 31, 2023 | -$8.18M | – |
| FY2022 | Dec 31, 2022 | -$10.08M | – |
| FY2021 | Dec 31, 2021 | -$12.83M | – |
| FY2020 | Dec 31, 2020 | -$14.13M | – |
| FY2019 | Dec 31, 2019 | -$11.99M | – |
| FY2018 | Dec 31, 2018 | -$5.40M | – |
See a number that looks wrong?